Actinium Pharmaceuticals
ATNM
ATNM
59 hedge funds and large institutions have $29.8M invested in Actinium Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 18
13% less capital invested
Capital invested by funds: $34.1M → $29.8M (-$4.36M)
Holders
59
Holding in Top 10
–
Calls
$535K
Puts
$359K
Top Buyers
| 1 | +$766K | |
| 2 | +$168K | |
| 3 | +$151K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$138K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$115K |
Top Sellers
| 1 | -$371K | |
| 2 | -$186K | |
| 3 | -$157K | |
| 4 |
BGIM
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
|
-$147K |
| 5 |
Invesco
Atlanta,
Georgia
|
-$112K |